Cargando…
Barriers and enablers of adherence to infant nevirapine prophylaxis against HIV 1 transmission among 6-week-old HIV exposed infants: A prospective cohort study in Northern Uganda
BACKGROUND: Sub-optimal adherence to infant prophylaxis has been associated with mother-to-child-transmission of HIV. However, the factors associated have not been well characterised in different settings. This study describes barriers and enablers of adherence to infant prophylaxis among 6-week-old...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7561159/ https://www.ncbi.nlm.nih.gov/pubmed/33057393 http://dx.doi.org/10.1371/journal.pone.0240529 |
_version_ | 1783595212270993408 |
---|---|
author | Napyo, Agnes Tylleskär, Thorkild Mukunya, David Tumuhamye, Josephine Musaba, Milton W. Ojok Arach, Anna Agnes Waako, Paul Tumwine, James K. Ndeezi, Grace |
author_facet | Napyo, Agnes Tylleskär, Thorkild Mukunya, David Tumuhamye, Josephine Musaba, Milton W. Ojok Arach, Anna Agnes Waako, Paul Tumwine, James K. Ndeezi, Grace |
author_sort | Napyo, Agnes |
collection | PubMed |
description | BACKGROUND: Sub-optimal adherence to infant prophylaxis has been associated with mother-to-child-transmission of HIV. However, the factors associated have not been well characterised in different settings. This study describes barriers and enablers of adherence to infant prophylaxis among 6-week-old HIV exposed infants in Lira district, Northern Uganda. METHODS: This prospective cohort study was conducted from 2018–2020 at the PMTCT clinic at Lira Regional Referral Hospital and included 472 mother-infant pairs. HIV-infected pregnant women were recruited, followed up at delivery and 6 weeks postpartum. We used a structured questionnaire to obtain data on socio-demographic, reproductive-related, HIV-related characteristics and adherence. Data were analysed using Stata to estimate adjusted risk ratios using Poisson regression models to ascertain barriers and enablers of adherence to infant nevirapine prophylaxis. RESULTS: Barriers to infant adherence are maternal characteristics including: younger age (≤20 years adjusted risk ratio (ARR) = 1.55; 95% CI: 1.1–2.2), missing a viral load test during pregnancy (ARR: 1.4; 95% CI: 1.1–1.7) and not receiving nevirapine syrup for the baby after childbirth (ARR = 6.2; 95% CI: 5.1–7.6). Enablers were: having attained ≥14 years of schooling (ARR = 0.7; 95% CI: 0.5–0.9), taking a nevirapine-based regimen (ARR = 0.6; 95% CI: 0.4–0.9), long-term ART (≥ 60 months ARR = 0.75; 95% CI: 0.6–0.9), accompanied by a husband to hospital during labour and childbirth (ARR = 0.5; 95% CI: 0.4–0.7) and labour starting at night (ARR = 0.7; 95% CI: 0.6–0.8). CONCLUSION AND RECOMMENDATIONS: Despite mothers receiving nevirapine syrup from the health workers for the infant, non-adherence rates still prevail at 14.8%. The health system needs to consider giving HIV infected pregnant women the nevirapine syrup before birth to avoid delays and non-adherence. There is need to pay particular attention to younger women and those who recently started ART. |
format | Online Article Text |
id | pubmed-7561159 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-75611592020-10-21 Barriers and enablers of adherence to infant nevirapine prophylaxis against HIV 1 transmission among 6-week-old HIV exposed infants: A prospective cohort study in Northern Uganda Napyo, Agnes Tylleskär, Thorkild Mukunya, David Tumuhamye, Josephine Musaba, Milton W. Ojok Arach, Anna Agnes Waako, Paul Tumwine, James K. Ndeezi, Grace PLoS One Research Article BACKGROUND: Sub-optimal adherence to infant prophylaxis has been associated with mother-to-child-transmission of HIV. However, the factors associated have not been well characterised in different settings. This study describes barriers and enablers of adherence to infant prophylaxis among 6-week-old HIV exposed infants in Lira district, Northern Uganda. METHODS: This prospective cohort study was conducted from 2018–2020 at the PMTCT clinic at Lira Regional Referral Hospital and included 472 mother-infant pairs. HIV-infected pregnant women were recruited, followed up at delivery and 6 weeks postpartum. We used a structured questionnaire to obtain data on socio-demographic, reproductive-related, HIV-related characteristics and adherence. Data were analysed using Stata to estimate adjusted risk ratios using Poisson regression models to ascertain barriers and enablers of adherence to infant nevirapine prophylaxis. RESULTS: Barriers to infant adherence are maternal characteristics including: younger age (≤20 years adjusted risk ratio (ARR) = 1.55; 95% CI: 1.1–2.2), missing a viral load test during pregnancy (ARR: 1.4; 95% CI: 1.1–1.7) and not receiving nevirapine syrup for the baby after childbirth (ARR = 6.2; 95% CI: 5.1–7.6). Enablers were: having attained ≥14 years of schooling (ARR = 0.7; 95% CI: 0.5–0.9), taking a nevirapine-based regimen (ARR = 0.6; 95% CI: 0.4–0.9), long-term ART (≥ 60 months ARR = 0.75; 95% CI: 0.6–0.9), accompanied by a husband to hospital during labour and childbirth (ARR = 0.5; 95% CI: 0.4–0.7) and labour starting at night (ARR = 0.7; 95% CI: 0.6–0.8). CONCLUSION AND RECOMMENDATIONS: Despite mothers receiving nevirapine syrup from the health workers for the infant, non-adherence rates still prevail at 14.8%. The health system needs to consider giving HIV infected pregnant women the nevirapine syrup before birth to avoid delays and non-adherence. There is need to pay particular attention to younger women and those who recently started ART. Public Library of Science 2020-10-15 /pmc/articles/PMC7561159/ /pubmed/33057393 http://dx.doi.org/10.1371/journal.pone.0240529 Text en © 2020 Napyo et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Napyo, Agnes Tylleskär, Thorkild Mukunya, David Tumuhamye, Josephine Musaba, Milton W. Ojok Arach, Anna Agnes Waako, Paul Tumwine, James K. Ndeezi, Grace Barriers and enablers of adherence to infant nevirapine prophylaxis against HIV 1 transmission among 6-week-old HIV exposed infants: A prospective cohort study in Northern Uganda |
title | Barriers and enablers of adherence to infant nevirapine prophylaxis against HIV 1 transmission among 6-week-old HIV exposed infants: A prospective cohort study in Northern Uganda |
title_full | Barriers and enablers of adherence to infant nevirapine prophylaxis against HIV 1 transmission among 6-week-old HIV exposed infants: A prospective cohort study in Northern Uganda |
title_fullStr | Barriers and enablers of adherence to infant nevirapine prophylaxis against HIV 1 transmission among 6-week-old HIV exposed infants: A prospective cohort study in Northern Uganda |
title_full_unstemmed | Barriers and enablers of adherence to infant nevirapine prophylaxis against HIV 1 transmission among 6-week-old HIV exposed infants: A prospective cohort study in Northern Uganda |
title_short | Barriers and enablers of adherence to infant nevirapine prophylaxis against HIV 1 transmission among 6-week-old HIV exposed infants: A prospective cohort study in Northern Uganda |
title_sort | barriers and enablers of adherence to infant nevirapine prophylaxis against hiv 1 transmission among 6-week-old hiv exposed infants: a prospective cohort study in northern uganda |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7561159/ https://www.ncbi.nlm.nih.gov/pubmed/33057393 http://dx.doi.org/10.1371/journal.pone.0240529 |
work_keys_str_mv | AT napyoagnes barriersandenablersofadherencetoinfantnevirapineprophylaxisagainsthiv1transmissionamong6weekoldhivexposedinfantsaprospectivecohortstudyinnorthernuganda AT tylleskarthorkild barriersandenablersofadherencetoinfantnevirapineprophylaxisagainsthiv1transmissionamong6weekoldhivexposedinfantsaprospectivecohortstudyinnorthernuganda AT mukunyadavid barriersandenablersofadherencetoinfantnevirapineprophylaxisagainsthiv1transmissionamong6weekoldhivexposedinfantsaprospectivecohortstudyinnorthernuganda AT tumuhamyejosephine barriersandenablersofadherencetoinfantnevirapineprophylaxisagainsthiv1transmissionamong6weekoldhivexposedinfantsaprospectivecohortstudyinnorthernuganda AT musabamiltonw barriersandenablersofadherencetoinfantnevirapineprophylaxisagainsthiv1transmissionamong6weekoldhivexposedinfantsaprospectivecohortstudyinnorthernuganda AT ojokarachannaagnes barriersandenablersofadherencetoinfantnevirapineprophylaxisagainsthiv1transmissionamong6weekoldhivexposedinfantsaprospectivecohortstudyinnorthernuganda AT waakopaul barriersandenablersofadherencetoinfantnevirapineprophylaxisagainsthiv1transmissionamong6weekoldhivexposedinfantsaprospectivecohortstudyinnorthernuganda AT tumwinejamesk barriersandenablersofadherencetoinfantnevirapineprophylaxisagainsthiv1transmissionamong6weekoldhivexposedinfantsaprospectivecohortstudyinnorthernuganda AT ndeezigrace barriersandenablersofadherencetoinfantnevirapineprophylaxisagainsthiv1transmissionamong6weekoldhivexposedinfantsaprospectivecohortstudyinnorthernuganda |